Skip to main navigation
Skip to search
Skip to main content
Prinses Máxima Centrum Home
Nederlands
English
Search content at Prinses Máxima Centrum
Home
Profiles
Research Groups
Equipment
Research output
Prizes
Activities
Press/Media
Further studies to ameliorate toxicity of carboplatin
W. W. Ten Bokkel Huinink
, M. W. Dercksen
,
H. Van Tinteren
Research output
:
Contribution to journal
›
Article
›
peer-review
5
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Further studies to ameliorate toxicity of carboplatin'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Carboplatin
100%
Cisplatin
66%
Anemia
33%
Ovarian Cancer
33%
Erythropoietin
33%
Platinating Agents
33%
Chemotherapy
16%
Bone Marrow
16%
Treatment Regimen
16%
Growth Factors
16%
Treatment Strategy
16%
Retrospective Analysis
16%
Clinical Practice
16%
Beneficial Effects
16%
Protective Effect
16%
Phase II Trial
16%
High Dose
16%
Headache
16%
Hematologic
16%
Treatment Course
16%
Myelosuppression
16%
High Response Rate
16%
Treatment Cycle
16%
Second-line Treatment
16%
Interleukin-3
16%
Erythropoietin Levels
16%
Historical Data
16%
Myeloprotective
16%
Kidney Function Decline
16%
During Treatment
16%
Subsequent Therapy
16%
Pharmacology, Toxicology and Pharmaceutical Science
Carboplatin
100%
Cisplatin
66%
Erythropoietin
50%
Anemia
33%
Ovary Cancer
33%
Growth Factor
16%
Chemotherapy Regimens
16%
Headache
16%
Bone Marrow Suppression
16%
Interleukin 3
16%
Phase III Trials
16%
Side Effect
16%